| Discovery and validation of novel biomarkers for detection of epithelial ovarian cancer H Kulbe, R Otto, S Darb-Esfahani, H Lammert, S Abobaker, G Welsch, ... Cells 8 (7), 713, 2019 | 39 | 2019 |
| CancerResource—updated database of cancer-relevant proteins, mutations and interacting drugs BO Gohlke, J Nickel, R Otto, M Dunkel, R Preissner Nucleic Acids Research 44 (D1), D932-D937, 2016 | 38 | 2016 |
| Basal subtype is predictive for response to cetuximab treatment in patient‐derived xenografts of squamous cell head and neck cancer K Klinghammer, R Otto, JD Raguse, AE Albers, I Tinhofer, I Fichtner, ... International Journal of Cancer 141 (6), 1215-1221, 2017 | 27 | 2017 |
| Combination of copanlisib with cetuximab improves tumor response in cetuximab-resistant patient-derived xenografts of head and neck cancer K Klinghammer, O Politz, T Eder, R Otto, JD Raguse, A Albers, ... Oncotarget 11 (41), 3688, 2020 | 13 | 2020 |
| Robust in-silico identification of cancer cell lines based on next generation sequencing R Otto, C Sers, U Leser Oncotarget 8 (21), 34310, 2017 | 12 | 2017 |
| Gene set enrichment analysis reveals individual variability in host responses in tuberculosis patients T Domaszewska, J Zyla, R Otto, SHE Kaufmann, J Weiner Frontiers in Immunology 12, 694680, 2021 | 5 | 2021 |
| A comparative analysis of human bone marrow–resident and peripheral memory B cells SC Becker, M Szyska, A Mensen, K Hellwig, R Otto, L Olfe, HD Volk, ... Journal of Allergy and Clinical Immunology 141 (5), 1911-1913. e7, 2018 | 4 | 2018 |
| Elevated Flt3L predicts long-term survival in patients with high-grade gastroenteropancreatic neuroendocrine neoplasms KM Detjen, R Otto, Y Giesecke, L Geisler, P Riemer, H Jann, C Grötzinger, ... Cancers 13 (17), 4463, 2021 | 3 | 2021 |
| Preclinical efficacy of copanlisib in cetuximab sensitive and resistant tumors of HNSCC. KF Klinghammer, O Politz, T Eder, R Otto, JD Raguse, J Hoffmann, ... Journal of Clinical Oncology 37 (15_suppl), 6031-6031, 2019 | 2 | 2019 |
| Robust in-silico identification of Cancer Cell Lines based on RNA and targeted DNA sequencing data R Otto, JN Rössler, C Sers, S Mamlouk, U Leser Scientific Reports 9 (1), 367, 2019 | 2 | 2019 |
| Distance-based methods for the analysis of Next-Generation sequencing data R Otto PQDT-Global, 2021 | 1 | 2021 |
| Molecular subtyping of head and neck cancer–Clinical applicability and correlations with morphological characteristics F Stögbauer, R Otto, K Jöhrens, I Tinhofer, U Keilholz, C Poremba, ... Oral Oncology 149, 106678, 2024 | | 2024 |
| Transcriptomic Deconvolution of Neuroendocrine Neoplasms Predicts Clinically Relevant Characteristics R Otto, KM Detjen, P Riemer, M Fattohi, C Grötzinger, G Rindi, ... Cancers 15 (3), 936, 2023 | | 2023 |
| MASTER THESIS EXPOS E U Leser, R Otto | | 2021 |
| SELECTED FOR ORAL PRESENTATION Transcriptomic deconvolution of neuroendocrine neoplasms predicts clinically relevant characteristics R Otto, K Detjen, P Riemer, C Groetzinger, G Rindi, B Wiedenmann, ... JOURNAL OF NEUROENDOCRINOLOGY 33, 40-40, 2021 | | 2021 |
| P135 Discovery and validation of novel biomarkers for detection of epithelial ovarian cancer H Kulbe, R Otto, S Darb-Esfahani, H Lammert, S Abobaker, G Welsch, ... International Journal of Gynecologic Cancer 29 (Suppl 4), 2019 | | 2019 |
| Prognostic impact of molecular subtypes of head and neck cancer R Otto, V Muenzer, K Joehrens, W Weichert, M Boxberg, ... ONCOLOGY RESEARCH AND TREATMENT 42, 56-56, 2019 | | 2019 |
| Distinct markers and functional traits define tissue-resident memory cells-towards an improved immune reconstitution after allogeneic hematopoietic stem cell transplantation SC Becker, M Szyska, A Mensen, K Hellwig, R Otto, L Olfe, L Vuong, ... ONCOLOGY RESEARCH AND TREATMENT 40, 39-39, 2017 | | 2017 |
| Human memory B cells reside in the bone marrow and are equipped with an alpha-defensin weapon-the bone marrow as a source for immunocompetent memory cells for transplantation S Becker, M Szyska, A Mensen, L Olfe, A Hocke, K Hellwig, L Vuong, ... BONE MARROW TRANSPLANTATION 52, S34-S34, 2017 | | 2017 |
| Basal subtype of head and neck cancer to define response to EGFR inhibitor treatment. KF Klinghammer, R Otto, JD Raguse, I Fichtner, A Albers, U Keilholz, ... Journal of Clinical Oncology 34 (15_suppl), e17512-e17512, 2016 | | 2016 |
